Support for the VACCINE Act (H.R. 2862)
Funding for microbiome research at the National Institutes of Health, the CDC, programs under the Assistant Secretary for Preparedness and Response and for the Global Health Security Agenda
Duration: June 1, 2018
to
December 31, 2019
General Issues: Health Issues , Budget/Appropriations , Disaster Planning/Emergencies
Spending: about $120,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2018: U.S. Senate, House of Representatives
Affiliated organizations: American Society for Microbiology
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2019
MGD Strategies LLC terminated an engagement in which they represented Summit Health Care Consulting, LLC on behalf of the ASM on Jan. 21, 2020.
Original Filing: 301124134.xml
Lobbying Issues
Support for the VACCINE Act (H.R. 2862)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding for microbiome research at the National Institutes of Health, the CDC, programs under the Assistant Secretary for Preparedness and Response and for the Global Health Security Agenda
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM , earning $30,000. The report was filed on Oct. 19, 2019.
Original Filing: 301072152.xml
Lobbying Issues
Support for the VACCINE Act (H.R. 2862)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Funding for microbiome research at the National Institutes of Health, the CDC, programs under the Assistant Secretary for Preparedness and Response and for the Global Health Security Agenda
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM , earning $20,000. The report was filed on July 18, 2019.
Original Filing: 301048928.xml
Lobbying Issues
support for the use of approved vaccines to prevent illness and death caused by infectious diseases
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Re-authorization of the Pandemic and All Hazards Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Funding for the National Institutes of Health, the CDC, programs under the Assistant Secretary for Preparedness and Response and for the Global Health Security Agenda
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM , earning $20,000. The report was filed on April 18, 2019.
Original Filing: 301030191.xml
Lobbying Issues
support for the use of approved vaccines to prevent illness and death caused by infectious diseases
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Re-authorization of the Pandemic and All Hazards Preparedness Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Disaster Planning/Emergencies
Lobbying Issues
Funding for the National Institutes of Health, the CDC, programs under the Assistant Secretary for Preparedness and Response and for the Global Health Security Agenda
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM , earning $10,000. The report was filed on Jan. 18, 2019.
Original Filing: 301007542.xml
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Disaster Planning/Emergencies
3rd Quarter, 2018
In Q3, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM , earning $10,000. The report was filed on Oct. 18, 2018.
Original Filing: 300987912.xml
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Disaster Planning/Emergencies
2nd Quarter, 2018
MGD Strategies LLC amended a lobbying report for representation of Summit Health Care Consulting, LLC on behalf of the ASM in Q22018 on July 23, 2018.
Original Filing: 300979197.xml
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Disaster Planning/Emergencies
2nd Quarter, 2018
In Q2, MGD Strategies LLC lobbied for Summit Health Care Consulting, LLC on behalf of the ASM . The report was filed on July 20, 2018.
Original Filing: 300972829.xml
Lobbying Issues
Reauthorization of the Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378) - Codifying the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB); including a specific authorization for the pandemic influenza program under the Biomedical Advanced Research Development Authority (BARDA); and strengthening of the Public Health Emergency Fund
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Health Issues Disaster Planning/Emergencies
2nd Quarter, 2018
MGD Strategies LLC (formerly known as "Megan M Don") filed a lobbying registration on July 9, 2018 to represent Summit Health Care Consulting, LLC on behalf of the ASM, effective June 1, 2018.
Original Filing: 300963047.xml
Issue(s) they said they’d lobby about: Reauthorization of the Pandemic and All-Hazards Preparedness Act. No specific legislation. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate